Mammen Mathai (CIK 0001421050)

Latest company ownership

INVA - Innoviva, Inc.
Role: SVP, Research & Early Clin Dev
Shares held
334,040
Last filed at
Aug 22, 2014
Confidence Score
50.0
2025Q4
Confidence Score History
2012Q3 2025Q4
TBPH - Theravance Biopharma, Inc.
Role: SVP, Research & Development
Shares held
288,111
Last filed at
Mar 17, 2016
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q1 2025Q4
TXG - 10x Genomics, Inc.
Role: Director
Shares held
180,259
Last filed at
Jun 13, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q2 2025Q4
JNJ - JOHNSON & JOHNSON
Role: EVP, Pharm, R&D
Shares held
7,740
Last filed at
Feb 17, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 11, 2023 May 15, 2023 10x Genomics, Inc. Director Sell 17.5 -33,000 -16.28% ✗ $1.7M
Feb 15, 2022 Feb 17, 2022 JOHNSON & JOHNSON EVP, Pharm, R&D Sell 20.0 -3,366 -7.43% ✗ $558.4K
Feb 14, 2022 Feb 15, 2022 JOHNSON & JOHNSON EVP, Pharm, R&D Sell 20.0 -2,335 -5.85% ✗ $394.3K
Feb 20, 2016 Feb 23, 2016 Theravance Biopharma, Inc. SVP, Research & Development Sell 20.0 -19,844 -9.10% ✗ $310.6K
Nov 20, 2015 Nov 24, 2015 Theravance Biopharma, Inc. SVP, Research & Development Sell 43.8 -934 -0.43% ✗ $16K
Aug 20, 2015 Aug 24, 2015 Theravance Biopharma, Inc. SVP, Research & Development Sell 43.8 -934 -0.42% ✗ $12.1K
Jun 2, 2015 Jun 4, 2015 Theravance Biopharma, Inc. SVP, Research & Development Sell 22.5 -7,360 -3.24% ✗ $101.8K
May 20, 2015 May 22, 2015 Theravance Biopharma, Inc. SVP, Research & Development Sell 45.0 -673 -0.30% ✗ $9.6K
Feb 20, 2015 Feb 24, 2015 Theravance Biopharma, Inc. SVP, Research & Development Sell 43.8 -674 -0.29% ✗ $13.2K
Aug 20, 2014 Aug 22, 2014 Innoviva, Inc. SVP, Research & Early Clin Dev Sell 32.5 -3,261 -0.97% ✗ $74.2K
May 9, 2014 May 12, 2014 Innoviva, Inc. SVP, Research & Early Clin Dev Sell 20.0 -24,033 -4.80% ✗ $613.3K
Feb 20, 2014 Feb 24, 2014 Innoviva, Inc. SVP, Research & Early Clin Dev Sell 22.5 -4,307 -2.31% ✗ $172.2K
Feb 14, 2014 Feb 19, 2014 Innoviva, Inc. SVP, Research & Early Clin Dev Sell 15.0 -35,000 -15.79% ✓ $1.4M
Nov 20, 2013 Nov 22, 2013 Innoviva, Inc. SVP, Research & Early Clin Dev Sell 22.5 -4,569 -2.02% ✗ $166.3K
Aug 20, 2013 Aug 22, 2013 Innoviva, Inc. SVP, Research & Early Clin Dev Sell 22.5 -3,813 -1.80% ✗ $136.8K
Jul 30, 2013 Aug 1, 2013 Innoviva, Inc. SVP, Research & Early Clin Dev Sell 35.0 -7,000 -3.20% ✓ $255.6K
May 20, 2013 May 22, 2013 Innoviva, Inc. SVP, Research & Early Clin Dev Sell 22.5 -3,292 -1.60% ✗ $121.8K
Apr 30, 2013 May 2, 2013 Innoviva, Inc. SVP, Research & Early Clin Dev Sell 37.5 -7,000 -3.29% ✓ $236.2K
Feb 20, 2013 Feb 22, 2013 Innoviva, Inc. SVP, Research & Early Clin Dev Sell 30.0 -12,002 -5.33% ✓ $265.5K
Nov 20, 2012 Nov 20, 2012 Innoviva, Inc. SVP, Research & Early Clin Dev Sell 22.5 -4,874 -2.31% ✗ $102.7K
Nov 2, 2012 Nov 6, 2012 Innoviva, Inc. SVP, Research & Early Clin Dev Sell 37.5 -7,000 -3.29% ✓ $150.2K
Aug 20, 2012 Aug 22, 2012 Innoviva, Inc. SVP, Research & Early Clin Dev Sell 22.5 -4,644 -2.19% ✗ $125.4K
Aug 13, 2012 Aug 15, 2012 Innoviva, Inc. SVP, Research & Early Clin Dev Sell 22.5 -25,000 -10.54% ✓ $643.5K